Article Information
History
- February 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alona Kuzmina1,*,
- Yara Khalaila2,
- Olga Voloshin2,
- Ayelet Keren-Naus1,2,
- Liora Bohehm2,
- Yael Raviv2,
- Yonat Shemer-Avni1,2,
- Elli Rosenberg2 and
- Ran Taube1,*
- 1The Shraga Segal Department of Microbiology Immunology and Genetics Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel
- 2Soroka Medical Center, Beer Sheva, Israel
- ↵*Correspondence: Ran Taube, Ph.D.; Alona Kuzmina PhD., The Shraga Segal Department of Microbiology Immunology and Genetics. Faculty of Health Sciences. Ben-Gurion University of the Negev, Beer Sheva, 84105. Israel, email: rantaube{at}bgu.ac.il.
Posted February 24, 2021.
SARS CoV-2 escape variants exhibit differential infectivity and neutralization sensitivity to convalescent or post-vaccination sera
